Protagonist Therapeutics (NASDAQ: PTGX) Stock Soars as Truist Raises PT
Protagonist Therapeutics (NASDAQ: PTGX) stock surged 46% on Monday after Truist Securities raised its price target from $60.00 to $76.00, […]
Protagonist Therapeutics (NASDAQ: PTGX) Stock Soars as Truist Raises PT Read More »
